CZO:CA Ceapro

CAD 0.24 -0.01 -2.083333
Icon

Ceapro (CZO:CA) Stock Analysis and Price Targets

COMMON STOCK | Biotechnology | TSV
stockTargetAdvisor

N/A

Average Analyst
Rating
stockTargetAdvisor

N/A

Top Analyst
Rating
stockTargetAdvisor

Slightly Bearish

Stock Target Advisor
Analysis
stockTargetAdvisor

N/A

Average User
Rating

CAD 0.235

-0.01 (-2.08)%

CAD 0.02B

0.07M

N/A

N/A

Icon

CZO:CA

Ceapro (CAD)
COMMON STOCK | TSV
CAD 0.24
0.00 0
Take a Tour
stockTargetAdvisor

N/A

Average Analyst
Rating
stockTargetAdvisor

N/A

Top Analyst
Rating
stockTargetAdvisor

Slightly Bearish

Stock Target Advisor
Analysis
stockTargetAdvisor

N/A

Average User
Rating

CAD 0.02B

N/A

CAD 0.24

Ceapro (CZO:CA) Stock Forecast

N/A

Based on the Ceapro stock forecast from 0 analysts, the average analyst target price for Ceapro is not available over the next 12 months. Ceapro’s average analyst rating is not available. Stock Target Advisor’s own stock analysis of Ceapro is Slightly Bearish, which is based on 3 positive signals and 4 negative signals. At the last closing, Ceapro’s stock price was CAD 0.235. Ceapro’s stock price has changed by -2.08% over the past week, +11.90% over the past month and -63.85% over the last year.

No recent analyst target price found for Ceapro
No recent average analyst rating found for Ceapro

Company Overview Ceapro

Ceapro Inc., a biotechnology company, engages in the development and marketing of health and wellness products and technology relating to plant extracts in the United States, Germany, China, Canada, and internationally. The company is involved in the development of proprietary ex...Read More

N/A

N/A

0

N/A

CAD

Canada

Adjusted Closing Price for Ceapro (CZO:CA)

Loading...

Unadjusted Closing Price for Ceapro (CZO:CA)

Loading...

Share Trading Volume for Ceapro Shares

Loading...

Compare Performance of Ceapro Shares

Symbol Capital Gain Dividend Return Total Return
Loading...
Loading...

Technical Indicators for CZO:CA

Assets

Top Holdings

Top Sectors

Top Regions

Stocks Similar To Ceapro (Sector: Biotechnology )

Symbol Name Price(Change) Market Cap Price / Earning Ratio EV/EBITDA
NGEN:CA
NervGen Pharma Corp +0.12 (+5.83%) CAD0.15B N/A -7.16

ETFs Containing CZO:CA

Symbol Name CZO:CA's Weight Expense Ratio Price(Change) Market Cap
no data

Frequently Asked Questions About Ceapro (CZO:CA) Stock

Stock Target Advisor's fundamental analysis for Ceapro's stock is Slightly Bearish.

Unfortunately we do not have enough data on CZO:CA's stock to indicate if its a good dividend stock.

Unfortunately we do not have enough data on CZO:CA's stock to indicate what its average analyst target is.

CZO:CA stock's Price/Earning ratio is 13.17. Our analysis grades CZO:CA stock's Price / Earning ratio at D+. This means that CZO:CA stock's Price/Earning ratio is above 32.99999999999999% of the stocks in the Biotechnology sector in the TSV exchange. Based on this CZO:CA may be fairly valued for its sector

The last closing price of CZO:CA's stock was CAD 0.24.

The most recent market capitalization for CZO:CA is CAD 0.02B.

Unfortunately we do not have enough analyst data on CZO:CA's stock to indicate whether its price will go up or not.

We can't find any ETFs which contains Ceapro's stock.

As per our most recent records Ceapro has 0 Employees.

Sorry we do not have any infomation available on Ceapro's address.
Heading 1 Heading 2 Heading 3 Heading 4 Heading 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5

Stock Target Advisor's Analysis

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

Icon
What to like

Icon
What not to like

Loading...